Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease

Accessible noninvasive screening tools for metabolic dysfunction-associated steatotic liver disease (MASLD) are needed. We aim to explore the performance of a deep-learning based artificial intelligence (AI) model in distinguishing the presence of MASLD using 12-lead electrocardiogram (ECG).